Journal of Cancer 2021, Vol. 12 3781 Ivyspring International Publisher Journal of Cancer 2021; 12(13): 3781-3795. doi: 10.7150/jca.51332 Research Paper INSL4 as prognostic marker for proliferation and invasiveness in Non-Small-Cell Lung Cancer Damiano Scopetti1*, Danilo Piobbico1*, Cinzia Brunacci1*, Stefania Pieroni1, Guido Bellezza2, Marilena Castelli1, Vienna Ludovini3, Francesca Romana Tofanetti3, Lucio Cagini4, Angelo Sidoni2, Efisio Puxeddu5, Maria Agnese Della-Fazia1, Giuseppe Servillo1 1. Department of Medicine and Surgery, Section of General Pathology, University of Perugia, Perugia- Italy. 2. Department of Medicine and Surgery, Section of Anatomic Pathology and Histology, University of Perugia, Perugia- Italy. 3. Medical Oncology, S. Maria Della Misericordia Hospital, Perugia, Italy. 4. Department of Medicine and Surgery, Section of internal medicine, angiology and atherosclerosis diseases. 5. Department of Medicine and Surgery, Section of internal medicine and endocrine and metabolic sciences. *These authors contributed equally to this work. Corresponding authors: Maria Agnese Della-Fazia & Giuseppe Servillo share senior authorship. Maria Agnese Della-Fazia, Department of Medicine and Surgery, University of Perugia, Piazzale L. Severi, 1, Perugia- Italy, tel. 075 5858111, E-mail:
[email protected]; Giuseppe Servillo, Department of Medicine and Surgery, University of Perugia, Piazzale L. Severi, 1, Perugia- Italy, tel. 075 5858110, e-mail:
[email protected]. © The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2021.01.31; Accepted: 2021.02.25; Published: 2021.05.05 Abstract Non-small-cell-lung cancer accounts for 80-85% of all forms of lung cancer as leading cause of cancer-related death in human.